 |
|
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
Eun-Jeong Kwon, Gi-Ae Yun, Seokwoo Park, Sejoong Kim, Dong-Wan Chae, Hyung Sub Park, Taeseung Lee, Jong Cheol Jeong
Kidney Res Clin Pract. 2022;41(6):768-770. Published online 2022 Nov 29 DOI: https://doi.org/10.23876/j.krcp.22.218
|
|
Citations to this article as recorded by
 Rescue Therapy for Supratherapeutic Concentrations of Calcineurin Inhibitors Using Potent Cytochrome P450 Inducers
Seth Duwor, Katharina Enthofer, Christoph Ganter, Prabin Poudel, Anna Svarin, Gerd A. Kullak-Ublick
Pharmacoepidemiology.2024; 3(1): 33. CrossRef Effect of rifampicin administration on CYP induction in a dermatomyositis patient with vasospastic angina attributable to nilmatrelvir/ritonavir-induced blood tacrolimus elevation: A case report
Hayato Akamatsu, Yusuke Kohno, Junya Hashizume, Hiroo Nakagawa, Yukinobu Kodama, Hiroaki Kawano, Koji Maemura, Kaname Ohyama
Journal of Infection and Chemotherapy.2024;[Epub] CrossRef Phenytoin enzyme induction for management of supratherapeutic tacrolimus levels due to drug-drug interaction with nirmatrelvir/ritonavir: Case series and discussion
Jennifer Marsh, Angela T Logan, Erin P Bilgili, Lyndsey J Bowman, Allyssa R Webb
American Journal of Health-System Pharmacy.2024;[Epub] CrossRef Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19
Wei Zhang, Xingguo Zhang, Jinming Han, Wen Zhang, Jiarui Xu, Xin Zhang, Hongjun Bian, Chong Meng, Deya Shang, Yi Zhou, Dawei Wang, Baobao Feng
Frontiers in Pharmacology.2024;[Epub] CrossRef Prevention and treatment strategies for kidney transplant recipients in the context of long-term existence of COVID-19
Zeyuan Zheng, Huimin Sun, Xiaoyan Hu, Zuodong Xuan, Meiling Fu, Yang Bai, Yifan Du, Bin Liu, Xiuyuan Sui, Jianzhong Zheng, Chen Shao
Frontiers in Medicine.2024;[Epub] CrossRef Nirmatrelvir+ritonavir/tacrolimus interaction
Reactions Weekly.2023; 1953(1): 321. CrossRef Drug–drug interaction of Nirmatrelvir/ritonavir and tacrolimus: A potential risk disproportionality analysis of nephrotoxicity from COVID-19 reports in FAERS
Fuhong Qin, Huiling Wang, Meng Li, Shengnan Zhuo, Wei Liu
Expert Opinion on Drug Safety.2023; 22(12): 1321. CrossRef Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-
Sabina Herrera, Jose M Aguado, Francisco Javier Candel, Elisa Cordero, Beatriz Domínguez-Gil, Mario Fernández-Ruiz, Ibai Los Arcos, Òscar Len, M. Ángeles Marcos, Elena Muñez, Patricia Muñoz, Isabel Rodríguez-Goncer, Javier Sánchez-Céspedes, Maricela Valer
Transplantation Reviews.2023; 37(4): 100788. CrossRef Case report: Supratherapeutic tacrolimus concentrations with nirmatrelvir/ritonavir in a lung transplant patient: a case report using Rifampin for reversal
Yu Xiong, Xiaoxing Wang, Shu Li, Qian Zhang, Lijuan Guo, Wenhui Chen, Zhixia Zhao, Lihong Liu
Frontiers in Pharmacology.2023;[Epub] CrossRef Drug-drug interaction between paxlovid and tacrolimus in a patient with myasthenia gravis and SARS-CoV-2 infection
Ying Chen, Wenbin Wan, Xiaoying Yao, Yangtai Guan
Journal of Neuroimmunology.2023; 385: 578245. CrossRef
|